{
  "completed": true,
  "status": "documented_historical_discovery_and_reconciliation",
  "provider": "Consensus",
  "provider_mode": "Historical browser/connector use as recorded in the source artifacts",
  "local_audit_date": "2026-10-09",
  "primary_comparison_count": null,
  "reported_usage": [],
  "grade_changed": false,
  "score_before": {
    "hsef_level": "Ζ",
    "hsef_descriptor": "Multiple independent causal lines converge",
    "confidence": "Moderate",
    "confidence_rationale": "65 primary reports with 5 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.",
    "rests_on_non_peer_reviewed_work": false,
    "rationale": "Ζ for the preregistered SC1 scope-matched emergence-restraint gate, with Η established-tumour control and Γ elimination-dominance reported separately. The nominal claim says suppresses emergence/progression, not that all cancers require failed immunity or that suppression must sterilize cells. Weakest-link Γ is an explicit sensitivity to the additional elimination-exclusive subclaim, not a reason to demote the nominal restraint claim. The assembled set crosses Δ/Ε/Ζ through temporally and antigen-resolved native tests, orthogonal innate/adaptive mechanisms, human immune-status contrasts and randomized residual-outgrowth prevention; no single broad-deficiency leg is used as the sole instrument."
  },
  "score_after": {
    "hsef_level": "Ζ",
    "hsef_descriptor": "Multiple independent causal lines converge",
    "confidence": "Moderate",
    "confidence_rationale": "65 primary reports with 5 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.",
    "rests_on_non_peer_reviewed_work": false,
    "rationale": "Ζ for the preregistered SC1 scope-matched emergence-restraint gate, with Η established-tumour control and Γ elimination-dominance reported separately. The nominal claim says suppresses emergence/progression, not that all cancers require failed immunity or that suppression must sterilize cells. Weakest-link Γ is an explicit sensitivity to the additional elimination-exclusive subclaim, not a reason to demote the nominal restraint claim. The assembled set crosses Δ/Ε/Ζ through temporally and antigen-resolved native tests, orthogonal innate/adaptive mechanisms, human immune-status contrasts and randomized residual-outgrowth prevention; no single broad-deficiency leg is used as the sole instrument."
  },
  "independent_blinded_audit": false,
  "raw_receipts": [
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_16_20_2026-10-05\\immune-surveillance-cancer\\consensus\\browser-proof.png",
      "sha256": "ef1eec362ac5cc9a554d10d897e4ce66ca846b3bd6e7206cb5f007799fda72c5"
    },
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_16_20_2026-10-05\\immune-surveillance-cancer\\consensus\\browser-provenance.json",
      "sha256": "c76aa66610ca059eb60accc91f26a1a84e7ec7515d3e48f1110ae4d9999c5b92"
    },
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_16_20_2026-10-05\\immune-surveillance-cancer\\consensus\\deep-dom.txt",
      "sha256": "60bb12c17ba2dca1d3ebdcbb92e8d829040ace3efadb13318a9bf16cc02deb3e"
    },
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_16_20_2026-10-05\\immune-surveillance-cancer\\consensus\\deep-response.txt",
      "sha256": "0d5bd021ece8937d251f414a3cd71ada834532d26cbce9433cefa7ca35587650"
    },
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_16_20_2026-10-05\\immune-surveillance-cancer\\consensus\\pro-dom.txt",
      "sha256": "a20bb51252787a481894b2ad96dff4d755fb921842eb4f2261d0f04a8778db2b"
    }
  ],
  "limitations": "This verifies documented historical use and links the record to the final edition. It adds no primary-source, full-text, independence or verification credit. Original access remains limited to the source-specific record."
}